These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 8554617)
21. Individual variation in the production and survival of F cells in sickle-cell disease. Dover GJ; Boyer SH; Charache S; Heintzelman K N Engl J Med; 1978 Dec; 299(26):1428-35. PubMed ID: 101847 [TBL] [Abstract][Full Text] [Related]
22. F-cell levels are altered with erythrocyte density in sickle cell disease. Basu S; Dash BP; Patel DK; Chakravarty S; Chakravarty A; Banerjee D; Chakrabarti A Blood Cells Mol Dis; 2011 Aug; 47(2):117-9. PubMed ID: 21592828 [TBL] [Abstract][Full Text] [Related]
23. Production of erythrocytes that contain fetal hemoglobin in anemia. Transient in vivo changes. Dover GJ; Boyer SH; Zinkham WH J Clin Invest; 1979 Feb; 63(2):173-6. PubMed ID: 429549 [TBL] [Abstract][Full Text] [Related]
24. Sparing effect of hemoglobin F and hemoglobin A2 on the polymerization of hemoglobin S at physiologic ligand saturations. Poillon WN; Kim BC; Rodgers GP; Noguchi CT; Schechter AN Proc Natl Acad Sci U S A; 1993 Jun; 90(11):5039-43. PubMed ID: 7685112 [TBL] [Abstract][Full Text] [Related]
25. The pharmacological manipulation of fetal haemoglobin: trials using hydroxyurea and recombinant human erythropoietin. el-Hazmi MA; al-Momen A; Warsy AS; Kandaswamy S; Huraib S; Harakati M; al-Mohareb F Acta Haematol; 1995; 93(2-4):57-61. PubMed ID: 7543719 [TBL] [Abstract][Full Text] [Related]
26. Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia. Charache S; Barton FB; Moore RD; Terrin ML; Steinberg MH; Dover GJ; Ballas SK; McMahon RP; Castro O; Orringer EP Medicine (Baltimore); 1996 Nov; 75(6):300-26. PubMed ID: 8982148 [TBL] [Abstract][Full Text] [Related]
27. Na+/H+ exchange is increased in sickle cell anemia and young normal red cells. Canessa M; Fabry ME; Suzuka SM; Morgan K; Nagel RL J Membr Biol; 1990 Jun; 116(2):107-15. PubMed ID: 2166162 [TBL] [Abstract][Full Text] [Related]
28. Early detection of response to hydroxyurea therapy in patients with sickle cell anemia. Ballas SK; McCarthy WF; Guo N; Brugnara C; Kling G; Bauserman RL; Waclawiw MA Hemoglobin; 2010; 34(5):424-9. PubMed ID: 20854115 [TBL] [Abstract][Full Text] [Related]
29. Absolute Reticulocyte Count Acts as a Surrogate for Fetal Hemoglobin in Infants and Children with Sickle Cell Anemia. Meier ER; Byrnes C; Weissman M; Lee YT; Miller JL PLoS One; 2015; 10(9):e0136672. PubMed ID: 26366562 [TBL] [Abstract][Full Text] [Related]
30. Clinical utility of flow cytometry in the study of erythropoiesis and nonclonal red cell disorders. Chesney A; Good D; Reis M Methods Cell Biol; 2011; 103():311-32. PubMed ID: 21722809 [TBL] [Abstract][Full Text] [Related]
31. Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease. Rodgers GP; Dover GJ; Uyesaka N; Noguchi CT; Schechter AN; Nienhuis AW N Engl J Med; 1993 Jan; 328(2):73-80. PubMed ID: 7677965 [TBL] [Abstract][Full Text] [Related]
34. Detection of hemoglobin variants in erythrocytes by flow cytometry. Campbell TA; Ware RE; Mason M Cytometry; 1999 Mar; 35(3):242-8. PubMed ID: 10082305 [TBL] [Abstract][Full Text] [Related]
35. Spectrum of fetal hemoglobin responses in sickle cell patients treated with hydroxyurea: the National Institutes of Health experience. Rodgers GP Semin Oncol; 1992 Jun; 19(3 Suppl 9):67-73. PubMed ID: 1379375 [TBL] [Abstract][Full Text] [Related]
36. Not all red cells sickle the same: Contributions of the reticulocyte to disease pathology in sickle cell anemia. Carden MA; Fasano RM; Meier ER Blood Rev; 2020 Mar; 40():100637. PubMed ID: 31735458 [TBL] [Abstract][Full Text] [Related]
37. The effect of fetal hemoglobin on the survival characteristics of sickle cells. Franco RS; Yasin Z; Palascak MB; Ciraolo P; Joiner CH; Rucknagel DL Blood; 2006 Aug; 108(3):1073-6. PubMed ID: 16861353 [TBL] [Abstract][Full Text] [Related]
38. Proteasome inhibition induces both antioxidant and hb f responses in sickle cell disease via the nrf2 pathway. Pullarkat V; Meng Z; Tahara SM; Johnson CS; Kalra VK Hemoglobin; 2014; 38(3):188-95. PubMed ID: 24670032 [TBL] [Abstract][Full Text] [Related]
39. Fetal hemoglobin levels in sickle cell disease and normal individuals are partially controlled by an X-linked gene located at Xp22.2. Dover GJ; Smith KD; Chang YC; Purvis S; Mays A; Meyers DA; Sheils C; Serjeant G Blood; 1992 Aug; 80(3):816-24. PubMed ID: 1379090 [TBL] [Abstract][Full Text] [Related]
40. Fetal characteristics of erythrocytes in sickle cell anemia: an immunofluorescence study of individual cells. Maniatis A; Papayannopoulou T; Bertles JF Blood; 1979 Jul; 54(1):159-68. PubMed ID: 444663 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]